Association of smoking with the efficacy of continuous glucose monitoring in type 1 diabetes: A propensity score-matched cohort study

Fernando Sebastian-Valles , Iñigo Hernando Alday , Maria Sara Tapia-Sanchiz , Juan José Raposo-López , Jon Garai Hierro , Victor Navas-Moreno , Julia Martínez-Alfonso , José Alfonso Arranz Martin , Miguel Antonio Sampedro-Nuñez , Mónica Marazuela
{"title":"Association of smoking with the efficacy of continuous glucose monitoring in type 1 diabetes: A propensity score-matched cohort study","authors":"Fernando Sebastian-Valles ,&nbsp;Iñigo Hernando Alday ,&nbsp;Maria Sara Tapia-Sanchiz ,&nbsp;Juan José Raposo-López ,&nbsp;Jon Garai Hierro ,&nbsp;Victor Navas-Moreno ,&nbsp;Julia Martínez-Alfonso ,&nbsp;José Alfonso Arranz Martin ,&nbsp;Miguel Antonio Sampedro-Nuñez ,&nbsp;Mónica Marazuela","doi":"10.1016/j.medcle.2024.10.027","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Smoking affects glycemic control in individuals with type 1 diabetes (T1D); however, its impact in the era of continuous glucose monitoring (CGM) has not been thoroughly studied.</div></div><div><h3>Materials and methods</h3><div>A retrospective cohort study was conducted at two centers, involving 405 T1D patients treated with multiple daily insulin injections and using CGM. The patients were matched using propensity scores based on sociodemographic and clinical characteristics. HbA1c levels were analysed before and after a 2.2-year follow-up period. The analysis was performed using mixed linear regression and multivariable conditional logistic models.</div></div><div><h3>Results</h3><div>The sample included 135 smokers and 270 non-smokers, with a mean age of 47.6 years, and 50.1% were women. Both groups had a similar baseline HbA1c of 8.0 (1.5%). After follow-up, non-smokers reduced their HbA1c to 7.3 (1.1%), while smokers only reduced it to 7.7 (1.3%), 95% CI [−0.57–0.10]). The proportion of non-smokers achieving HbA1c &lt;7% increased from 25% to 38.1%, 95% CI [0.14–0.36, whereas smokers showed no change (25.9%, 95% CI [−0.13–0.21]). Smoking was independently associated with a higher risk of not achieving HbA1c &lt;7%, despite CGM use (odds ratio 1.89, 95% CI [1.13–3.17].</div></div><div><h3>Conclusion</h3><div>Smoking limits the glycemic control benefits of CGM in individuals with T1D. It is crucial to include smokers in clinical trials and to develop strategies to discourage smoking in this population to maximise the benefits of diabetes technology.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"164 8","pages":"Pages 396-402"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2387020625001469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Smoking affects glycemic control in individuals with type 1 diabetes (T1D); however, its impact in the era of continuous glucose monitoring (CGM) has not been thoroughly studied.

Materials and methods

A retrospective cohort study was conducted at two centers, involving 405 T1D patients treated with multiple daily insulin injections and using CGM. The patients were matched using propensity scores based on sociodemographic and clinical characteristics. HbA1c levels were analysed before and after a 2.2-year follow-up period. The analysis was performed using mixed linear regression and multivariable conditional logistic models.

Results

The sample included 135 smokers and 270 non-smokers, with a mean age of 47.6 years, and 50.1% were women. Both groups had a similar baseline HbA1c of 8.0 (1.5%). After follow-up, non-smokers reduced their HbA1c to 7.3 (1.1%), while smokers only reduced it to 7.7 (1.3%), 95% CI [−0.57–0.10]). The proportion of non-smokers achieving HbA1c <7% increased from 25% to 38.1%, 95% CI [0.14–0.36, whereas smokers showed no change (25.9%, 95% CI [−0.13–0.21]). Smoking was independently associated with a higher risk of not achieving HbA1c <7%, despite CGM use (odds ratio 1.89, 95% CI [1.13–3.17].

Conclusion

Smoking limits the glycemic control benefits of CGM in individuals with T1D. It is crucial to include smokers in clinical trials and to develop strategies to discourage smoking in this population to maximise the benefits of diabetes technology.
吸烟与1型糖尿病患者持续血糖监测效果的关系:一项倾向评分匹配的队列研究
吸烟影响1型糖尿病(T1D)患者的血糖控制;然而,其在连续血糖监测(CGM)时代的影响尚未得到深入研究。材料与方法在两个中心进行回顾性队列研究,纳入405例每日多次胰岛素注射和CGM治疗的T1D患者。使用基于社会人口学和临床特征的倾向评分对患者进行匹配。在2.2年随访期前后分析HbA1c水平。分析使用混合线性回归和多变量条件逻辑模型进行。结果吸烟者135例,非吸烟者270例,平均年龄47.6岁,女性占50.1%。两组基线HbA1c相似,均为8.0(1.5%)。随访后,非吸烟者的HbA1c降至7.3(1.1%),而吸烟者仅降至7.7 (1.3%),95% CI[−0.57-0.10])。非吸烟者达到HbA1c <;7%的比例从25%增加到38.1%,95% CI[0.14-0.36],而吸烟者没有变化(25.9%,95% CI[- 0.13-0.21])。吸烟与HbA1c达不到7%的风险独立相关,尽管使用了CGM(优势比1.89,95% CI[1.13-3.17])。结论吸烟限制了糖尿病患者CGM的血糖控制效果。将吸烟者纳入临床试验,并制定策略阻止这一人群吸烟,以最大限度地发挥糖尿病技术的益处,这一点至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信